Download free PDF

Digital Psychotherapeutics Market Size & Share 2023 to 2032

Market Size by Solution (Monotherapy, Combination), by Application (Prevention, Management, Treatment), by Indication (Phobias and Anxiety, Psychotic), by Business Model (Direct-to-patients.

Report ID: GMI7175
   |
Published Date: October 2023
 | 
Report Format: PDF

Download Free PDF

Digital Psychotherapeutics Market Size

Digital Psychotherapeutics Market size was valued at around USD 1.2 billion in 2022 and is estimated to account over USD 16.9 billion by 2032. The prevalence of psychological disorders such as depression, anxiety, and stress-related ailments is rising globally. The increased prevalence of psychological disorders is boosting the demand for accessible and effective treatment choices, thus, fueling the expansion of digital psychotherapeutics.

Digital Psychotherapeutics Market Key Takeaways

Market Size & Growth

  • 2022 Market Size: USD 1.2 Billion
  • 2032 Forecast Market Size: USD 16.9 Billion
  • CAGR (2023–2032): 29.4%

Key Market Drivers

  • Rising prevalence of mental health disorders.
  • Increasing technological advancements in digital psychotherapeutics.
  • Growing awareness of mental health issues.

Challenges

  • Lack of clinical validation.
  • Limited access to technology.

 

For instance, according to Australian Bureau of Statistics, in 2022, 21.5% of people had a 12-month mental disorder, with anxiety being the most common group (17.2% of people aged 16–85 years). In addition, according to World Health Organisation (WHO) fact sheet 2022, 1 out of every 8 individuals in this world suffers from a psychological disorder. Moreover, growing awareness of mental health concerns has reduced stigma and increased individuals' willingness to seek treatment. Individuals are becoming more self-aware of their mental health, that has substantially increased the demand for digital psychotherapeutics.

 

Digital psychotherapeutics are evidence-based therapy treatments and services given through digital technology and software applications. These treatments are intended to test, cure, or aid people suffering from a variety of psychological conditions, such as depression, anxiety, stress, and mood disorders.

 

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the digital psychotherapeutics market. Due to reasons such as social isolation, economic uncertainty, and fear of the virus, the pandemic raised stress, anxiety, depression, and other mental health concerns. This spike in demand for mental health treatments resulted in a higher dependence on digital psychotherapeutics. Furthermore, the pandemic has pushed the use of remote patient monitoring and data analytics in mental health treatment. To deliver more personalised and effective therapies, digital platforms began to gather and analyse patient data.
 

Digital Psychotherapeutics Market

Digital Psychotherapeutics Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as increase in adoption of teletherapy, growing demand for mental health apps, and virtual reality (VR) therapy.
 

  • Artificial intelligence (AI) in healthcare and chatbot integration into mental health applications and platforms provide automated help, advice, and interventions. These AI-powered systems seek to provide personalized mental health care to the user.
     
  • Moreover, wearable medical devices, such as fitness trackers and smartwatches, began to integrate mental health monitoring and intervention features to provide a more holistic approach to well-being. In addition, healthcare institutions and providers are progressively integrating digital psychotherapy services into their service offerings, making them more broadly available to patients and a frequent part of comprehensive treatment initiatives
     

Digital Psychotherapeutics Market Analysis

Digital Psychotherapeutics Market Size, By Solution, 2021 - 2032 (USD Billion)

The market by solution is categorized into monotherapy and combination therapy. The combination therapy segment garnered USD 836 million revenue in 2022.
 

  • Combining several therapy techniques can result in improved treatment efficacy. Different treatment modalities can address different aspects of a mental health condition, providing an enhanced and personalized treatment plan. Individuals suffering from depression or anxiety, for example, may benefit from a combination of CBT provided via a mobile app and periodic teletherapy sessions.
     
  • Furthermore, combination therapy may assist with bridge treatment gaps, ensuring that people receive care when they need it. This is critical in closing the mental health care gap, where many people do not receive proper treatment. In addition, the digital psychotherapeutics industry has adopted emerging technologies such as AI, and VR, along with wearable devices. These technologies and products can be efficiently combined to give novel and effective digital therapeutics options.
     
Digital Psychotherapeutics Market Share, By Application (2022)

Based on application, the digital psychotherapeutics market is segmented into prevention, management, and treatment. The treatment segment accounted for over 58.2% market share in 2022 and is anticipated to witness fastest growth during the forecast period.

 

  • It offers greater accessibility to mental health treatment and allow individuals to receive treatment from the comfort of their homes, thereby, reducing geographical barriers and making it more convenient. In addition, digital therapy can be more discreet and may help individuals overcome the stigma associated with seeking mental health treatment in traditional settings. This encourages more people to seek professional help or consultation for mental health.
     
  • Moreover, several digital psychotherapy services are less expensive than traditional in-person treatment. This factor has the potential to make mental health therapy more accessible to a larger population. Additionally, growing awareness of mental health disorders and the significance of getting assistance whenever required has resulted in a rise in treatment demand.
     

Based on indication, the digital psychotherapeutics market is segmented into phobias and anxiety disorders, psychotic disorders, and other indications. The phobias and anxiety disorders segment accounted for over 42% market share in 2022.
 

  • Anonymity provided by digital psychotherapeutics can significantly assist patients in reducing the stigma associated with phobias and anxiety disorders. The anonymity of online therapy and self-help applications encourages more individuals to seek treatment.
     
  • Additionally, digital solutions are highly accessible, allowing individuals to receive treatment and support from the comfort of their homes. This convenience is particularly valuable for those who may find it difficult to attend in-person therapy sessions due to their phobias or anxiety. Moreover, virtual reality (VR) technology is increasingly used in the treatment of phobias and anxiety disorders. VR-based exposure therapy allows individuals to confront their fears in a controlled, immersive environment, making it a powerful driver for treatment landscape.
     

The digital psychotherapeutics market by business model is categorized into direct-to-patients/consumers, and Business-to-Business (B2B). The direct-to-patients/consumers segment accounted for around USD 893 million revenue size in 2022.

 

  • The accessibility and convenience provided by digital psychotherapeutics is among the primary drivers for direct-to-patients/consumers segment. Individuals can access treatment from the comfort of their own homes, eliminating the need for travel and shortening the time and effort required for in-person therapy.
     
  • Additionally, to personalize treatment programmes, digital platforms employ data-driven insights. This personalization ensures that interventions are specific to each individual's distinct requirements, preferences, and development. Moreover, DTC services provide rapid access to mental health aid. This is critical for those who require immediate assistance, such as those suffering from extreme stress, anxiety, or crisis situations.
     
North America Digital Psychotherapeutics Market, 2020- 2032 (USD Million)

North America digital psychotherapeutics market accounted for USD 700.3 million revenue in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

  • North America has seen a significant increase in mental health awareness, with a growing recognition of the importance of mental well-being. Public discourse and advocacy efforts have reduced stigma, encouraging more individuals to seek mental health support.
     
  • Furthermore, the region has a relatively high prevalence of mental health disorders, including depression, anxiety, and substance use disorders. This high prevalence drives the demand for accessible and effective mental health treatment. In addition, North America is a hub for technological innovation. The region has a strong focus on research and development in the field of digital health, leading to the creation of advanced digital psychotherapeutic solutions.
     

Digital Psychotherapeutics Market Share 

The digital psychotherapeutics industry is fragmented in nature, with a large number of small and medium-sized companies competing with each other. However, there are a few larger companies that are focusing on improving their market share. Prominent players such as Pear Therapeutics, SilverCloud Health, and Woebot Health hold a notable share in the market. These companies are diligently directing their efforts towards continuous solution innovation to gain substantial market share.
 

Some of the eminent market participants operating in the digital psychotherapeutics industry include:

  • Novartis AG
  • Pear Therapeutics
  • SilverCloud Health
  • Woebot Health
  • Starling Minds
  • SwissDT
  • AbleTo, Inc.
  • Spring Care, Inc
  • Meru
  • Ginger

Digital Psychotherapeutics Industry News:

  • In August 2022, CarePaths Inc. has announced the launched of CarePaths Connect, a new mobile app that extends its mental health EHR platform with numerous features aimed at increasing patient participation and improving outcomes.
     

Digital psychotherapeutics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

By Solution, 2018-2032 (USD Million)

  • Monotherapy
  • Combination therapy

By Application, 2018-2032 (USD Million)

  • Prevention
  • Management
  • Treatment

By Indication, 2018-2032 (USD Million)

  • Phobias and anxiety disorders
  • Psychotic disorders
  • Other indications

By Business model, 2018-2032 (USD Million)

  • Direct-to-patients/consumers
  • Business-to-Business (B2B)

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East & Africa

 

Authors:  Monali Tayade, Jignesh Rawal

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the size of the digital psychotherapeutics market?
Digital psychotherapeutics industry reached around USD 1.2 billion in revenue in 2022 and is projected to be worth USD 16.9 billion by 2032 owing to the rising prevalence of psychological disorders and the surging demand for accessible and effective treatment choices.
Why is the demand for digital psychotherapeutics combination therapy gaining traction?
The combination therapy segment generated USD 836 million in 2022 and is estimated to witness high demand through 2032 attributed to its improved treatment efficacy.
How big is the North America digital psychotherapeutics industry?
North America digital psychotherapeutics industry amassed USD 700.3 million in revenue in 2022 and is set to witness robust growth through 2032 with the increasing mental health awareness and the growing recognition of the importance of mental well-being in the region.
Which are the leading firms operating in the digital psychotherapeutics market?
The competitive landscape of the digital psychotherapeutics industry includes prominent firms, such as Novartis AG, Pear Therapeutics, SilverCloud Health, Woebot Health, Starling Minds, SwissDT, AbleTo, Inc., Spring Care, Inc, Meru, and Ginger.
Digital Psychotherapeutics Market Scope
  • Digital Psychotherapeutics Market Size

  • Digital Psychotherapeutics Market Trends

  • Digital Psychotherapeutics Market Analysis

  • Digital Psychotherapeutics Market Share

Authors:  Monali Tayade, Jignesh Rawal
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2022

Companies Profiled: 10

Tables & Figures: 264

Countries Covered: 22

Pages: 160

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)